Upstream Bio, Inc. (UPB)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Treatments for Inflammatory Diseases	2.37M	Log In	Log In
Treatments for Inflammatory Diseases Growth	-0.42%	Log In	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Japan	2.37M	Log In	Log In
Japan Growth	-0.42%	Log In	Log In